Rifino N, Aamodt AH, Wiedmann M, Kramer M, Becker J, Guey S, Acerbi F, Herve D, Bersano A (2026)
Response to the Letter to the Editor: "Reaffirming Caution-The Unacceptable Vasoconstrictive Risk of CGRP-Related Therapies in Moyamoya Angiopathy"
Eur J Neurol, 33 (1), e70470
DOI 10.1111/ene.70470, PubMed 41508730

Lemke JR, Eoli A, Krey I, Popp B, Strehlow V, Wittekind DA, Vuorinen AL, Aldhalaan HM, Baer S, de Saint Martin A, Hammer TB, Herman I, Hornemann F, Ingebrigtsen T, Lederer D, Lesca G, Marafie D, Mathot M, Rosenfeld JA, Møller RS, Schelhaas HJ, Stillman C, Orsini A, Patel AD, Piard J et al. (2026)
Correction: GRIN2A null variants confer a high risk for early-onset schizophrenia and other mental disorders and potentially enable precision therapy
Mol Psychiatry (in press)
DOI 10.1038/s41380-025-03442-x, PubMed 41501486

McWilliams EC, Milanovic SM, Elvsåshagen T, Lew R, Hopkins SC, Andrews C, Walling DP, Islam MN, Nolan H, Koblan KS, Murphy B (2026)
A brief visual evoked potential (VEP) modulation assessment of experience-dependent plasticity recorded via wireless dry-EEG headset in Phase 1 clinical units
Sci Rep, 16 (1), 620
DOI 10.1038/s41598-025-29950-y, PubMed 41495123